Veracyte PE Ratio 2012-2026 | VCYT
Current and historical p/e ratio for Veracyte (VCYT) from 2012 to 2026. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Veracyte PE ratio as of September 14, 2026 is 27.11.
| Veracyte PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-09-15 | 40.14 | 28.67 | |
| 2026-06-30 | 58.73 | $1.40 | 41.95 |
| 2026-03-31 | 32.21 | $1.08 | 29.82 |
| 2025-12-31 | 42.10 | $0.82 | 51.34 |
| 2025-09-30 | 34.33 | $0.39 | 88.03 |
| 2025-06-30 | 27.03 | $0.34 | 79.50 |
| 2025-03-31 | 29.65 | $0.42 | 70.60 |
| 2024-12-31 | 39.60 | $0.31 | 127.74 |
| 2024-09-30 | 34.04 | $-0.14 | 0.00 |
| 2024-06-30 | 21.67 | $-0.74 | 0.00 |
| 2024-03-31 | 22.16 | $-0.93 | 0.00 |
| 2023-12-31 | 27.51 | $-1.02 | 0.00 |
| 2023-09-30 | 22.33 | $-0.70 | 0.00 |
| 2023-06-30 | 25.47 | $-0.41 | 0.00 |
| 2023-03-31 | 22.30 | $-0.42 | 0.00 |
| 2022-12-31 | 23.73 | $-0.51 | 0.00 |
| 2022-09-30 | 16.60 | $-0.57 | 0.00 |
| 2022-06-30 | 19.90 | $-0.65 | 0.00 |
| 2022-03-31 | 27.57 | $-0.65 | 0.00 |
| 2021-12-31 | 41.20 | $-1.11 | 0.00 |
| 2021-09-30 | 46.45 | $-1.11 | 0.00 |
| 2021-06-30 | 39.98 | $-0.99 | 0.00 |
| 2021-03-31 | 53.75 | $-1.08 | 0.00 |
| 2020-12-31 | 48.94 | $-0.66 | 0.00 |
| 2020-09-30 | 32.49 | $-0.69 | 0.00 |
| 2020-06-30 | 25.90 | $-0.63 | 0.00 |
| 2020-03-31 | 24.31 | $-0.46 | 0.00 |
| 2019-12-31 | 27.92 | $-0.27 | 0.00 |
| 2019-09-30 | 24.00 | $-0.17 | 0.00 |
| 2019-06-30 | 28.51 | $-0.27 | 0.00 |
| 2019-03-31 | 25.02 | $-0.40 | 0.00 |
| 2018-12-31 | 12.58 | $-0.62 | 0.00 |
| 2018-09-30 | 9.55 | $-0.81 | 0.00 |
| 2018-06-30 | 9.34 | $-0.90 | 0.00 |
| 2018-03-31 | 5.56 | $-0.94 | 0.00 |
| 2017-12-31 | 6.53 | $-0.91 | 0.00 |
| 2017-09-30 | 8.77 | $-0.80 | 0.00 |
| 2017-06-30 | 8.33 | $-0.79 | 0.00 |
| 2017-03-31 | 9.18 | $-0.97 | 0.00 |
| 2016-12-31 | 7.74 | $-1.09 | 0.00 |
| 2016-09-30 | 7.61 | $-1.25 | 0.00 |
| 2016-06-30 | 5.03 | $-1.37 | 0.00 |
| 2016-03-31 | 5.40 | $-1.32 | 0.00 |
| 2015-12-31 | 7.20 | $-1.30 | 0.00 |
| 2015-09-30 | 4.69 | $-1.37 | 0.00 |
| 2015-06-30 | 11.14 | $-1.42 | 0.00 |
| 2015-03-31 | 7.28 | $-1.38 | 0.00 |
| 2014-12-31 | 9.66 | $-1.36 | 0.00 |
| 2014-09-30 | 9.75 | $16.01 | 0.61 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $3.313B | $0.517B |
| Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also developing Afirma Malignant GEC test. It serves endocrinologists, radiologists, and head and neck specialists. Veracyte, Inc. is headquartered in South San Francisco, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $226.884B | 25.75 |
| Intuitive Surgical (ISRG) | United States | $133.518B | 45.26 |
| Edwards Lifesciences (EW) | United States | $49.242B | 30.43 |
| IQVIA Holdings (IQV) | United States | $43.729B | 23.39 |
| Waters (WAT) | United States | $40.283B | 29.97 |
| IDEXX Laboratories (IDXX) | United States | $40.144B | 35.83 |
| Alcon (ALC) | Switzerland | $33.505B | 20.78 |
| DexCom (DXCM) | United States | $31.955B | 33.21 |
| Mettler-Toledo (MTD) | United States | $25.762B | 28.65 |
| STERIS (STE) | Ireland | $20.832B | 20.50 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.759B | 0.00 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| Coloplast (CLPBY) | Denmark | $14.762B | 17.70 |
| Penumbra (PEN) | United States | $12.599B | 83.08 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.279B | 8.59 |
| Globus Medical (GMED) | United States | $10.173B | 15.40 |
| Glaukos (GKOS) | United States | $10.092B | 0.00 |
| Masimo (MASI) | United States | $9.578B | 30.69 |
| SARTORIUS (SSSGY) | Germany | $7.521B | 43.67 |
| Sysmex ADR (SSMXY) | Japan | $7.390B | 27.95 |
| Teleflex (TFX) | United States | $5.521B | 14.89 |
| LivaNova (LIVN) | United Kingdom | $4.442B | 22.46 |
| Integer Holdings (ITGR) | United States | $4.287B | 19.86 |
| Pulse Biosciences (PLSE) | United States | $3.752B | 0.00 |
| TransMedics (TMDX) | United States | $2.967B | 43.58 |
| AxoGen (AXGN) | United States | $2.354B | 0.00 |
| UFP Technologies (UFPT) | United States | $2.153B | 27.17 |
| Elekta AB (EKTAY) | Sweden | $1.883B | 17.62 |
| Nihon Kohden (NHNKY) | Japan | $1.694B | 15.52 |
| Alphatec Holdings (ATEC) | United States | $1.677B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $1.301B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.222B | 6.36 |
| Artivion (AORT) | United States | $1.217B | 46.24 |
| PROCEPT BioRobotics (PRCT) | United States | $1.204B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.171B | 27.77 |
| Tandem Diabetes Care (TNDM) | United States | $1.170B | 0.00 |
| OPKO Health (OPK) | United States | $1.164B | 0.00 |
| IRadimed (IRMD) | United States | $1.055B | 46.11 |
| Anteris Technologies Global (AVR) | Australia | $0.850B | 0.00 |
| SiBone (SIBN) | United States | $0.829B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.753B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.680B | 16.37 |
| AngioDynamics (ANGO) | United States | $0.641B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.583B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.570B | 1644.00 |
| Tactile Systems Technology (TCMD) | United States | $0.511B | 20.90 |
| NeuroPace (NPCE) | United States | $0.501B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.448B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.420B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.411B | 0.00 |
| 908 Devices (MASS) | United States | $0.402B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.371B | 0.00 |
| Mobia Medical (MOBI) | United States | $0.334B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Treace Medical Concepts (TMCI) | United States | $0.301B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.266B | 0.00 |
| RxSight (RXST) | United States | $0.254B | 0.00 |
| Neuronetics (STIM) | United States | $0.221B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.159B | 0.00 |
| FocalTherics (FOCL) | France | $0.154B | 0.00 |
| Inogen (INGN) | United States | $0.139B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.124B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| LENSAR (LNSR) | United States | $0.096B | 0.00 |
| Hyperfine (HYPR) | United States | $0.085B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.083B | 0.00 |
| CVRx (CVRX) | United States | $0.080B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.071B | 23.27 |
| DarioHealth (DRIO) | United States | $0.069B | 0.00 |
| Positron (POSC) | United States | $0.059B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.059B | 0.00 |
| Envoy Medical (COCH) | United States | $0.056B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.055B | 0.00 |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.052B | 0.00 |
| Precision Optics (POCI) | United States | $0.048B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.045B | 0.00 | |
| InspireMD (NSPR) | United States | $0.038B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.036B | 0.00 |
| PAVmed (PAVM) | United States | $0.035B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.032B | 0.00 |
| Accuray (ARAY) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.010B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| NexGel (NXGL) | United States | $0.003B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.000B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |